TRCT
MNOV icon

Tower Research Capital (TRC)’s MediciNova MNOV Stock Holding History

Tower Research Capital (TRC)’s Portfolio MNOV Stock Details MNOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,846
Closed -$2.42K – 5389
2025
Q4 		$2.42K Sell
1,846
-363
-16% -$501 ﹤0.01% 4533
2025
Q3 		$2.81K Sell
2,209
-1,253
-36% -$1.62K ﹤0.01% 4581
2025
Q2 		$4.54K Buy
3,462
+234
+7% +$328 ﹤0.01% 4309
2025
Q1 		$4.71K Sell
3,228
-124
-4% -$219 ﹤0.01% 4208
2024
Q4 		$7.04K Buy
3,352
+1,031
+44% +$2.01K ﹤0.01% 4109
2024
Q3 		$4.87K Sell
2,321
-4,208
-64% -$6.23K ﹤0.01% 4394
2024
Q2 		$9.4K Sell
6,529
-4,061
-38% -$5.69K ﹤0.01% 4257
2024
Q1 		$15.4K Buy
10,590
+2,453
+30% +$3.48K ﹤0.01% 3249
2023
Q4 		$12.2K Sell
8,137
-1,143
-12% -$2.07K ﹤0.01% 4067
2023
Q3 		$19.4K Buy
9,280
+667
+8% +$1.55K ﹤0.01% 3407
2023
Q2 		$19.8K Sell
8,613
-11,916
-58% -$26.3K ﹤0.01% 3396
2023
Q1 		$44K Sell
20,529
-15,629
-43% -$35.8K ﹤0.01% 2616
2022
Q4 		$74K Buy
36,158
+31,801
+730% +$70.2K ﹤0.01% 2061
2022
Q3 		$10K Sell
4,357
-3,645
-46% -$8.44K ﹤0.01% 4549
2022
Q2 		$20K Buy
8,002
+3,508
+78% +$9.15K ﹤0.01% 3794
2022
Q1 		$12K Buy
4,494
+4,231
+1,609% +$10.4K ﹤0.01% 4078
2021
Q4 		$1K Sell
263
-5,788
-96% -$19.3K ﹤0.01% 5854
2021
Q3 		$23K Sell
6,051
-1,819
-23% -$6.91K ﹤0.01% 3600
2021
Q2 		$34K Buy
7,870
+3,782
+93% +$16.3K ﹤0.01% 3352
2021
Q1 		$21K Sell
4,088
-6,895
-63% -$40.1K ﹤0.01% 3842
2020
Q4 		$58K Sell
10,983
-32,578
-75% -$187K ﹤0.01% 2951
2020
Q3 		$228K Buy
43,561
+33,015
+313% +$190K ﹤0.01% 2453
2020
Q2 		$57K Buy
+10,546
New +$55.9K ﹤0.01% 2950
2020
Q1 		– Sell
-61
Closed – – 3563
2019
Q4 		$0 Sell
61
-5,507
-99% -$41.4K ﹤0.01% 4064
2019
Q3 		$44K Sell
5,568
-3,469
-38% -$30.9K ﹤0.01% 1886
2019
Q2 		$87K Buy
9,037
+3,785
+72% +$39.9K 0.01% 1252
2019
Q1 		$44K Buy
5,252
+932
+22% +$8.13K ﹤0.01% 1831
2018
Q4 		$36K Buy
4,320
+4,257
+6,757% +$42.5K ﹤0.01% 1509
2018
Q3 		$1K Buy
+63
New +$633 ﹤0.01% 3604
2018
Q2 		– Sell
-1,441
Closed -$15K – 3904
2018
Q1 		$15K Sell
1,441
-649
-31% -$6.47K ﹤0.01% 2303
2017
Q4 		$14K Sell
2,090
-1,574
-43% -$10.4K ﹤0.01% 2324
2017
Q3 		$23K Buy
+3,664
New +$19.5K ﹤0.01% 2645
2017
Q2 		– Sell
-300
Closed -$2K – 3163
2017
Q1 		$2K Sell
300
-2,901
-91% -$17.5K ﹤0.01% 2639
2016
Q4 		$19K Buy
+3,201
New +$22.5K ﹤0.01% 2198
2016
Q3 		– Sell
-1,508
Closed -$11K – 4122
2016
Q2 		$11K Buy
1,508
+955
+173% +$6.91K ﹤0.01% 2733
2016
Q1 		$4K Buy
553
+30
+6% +$149 ﹤0.01% 2900
2015
Q4 		$2K Buy
+523
New +$1.66K ﹤0.01% 3765
2015
Q3 		– Sell
-200
Closed -$1K – 4482
2015
Q2 		$1K Sell
200
-162
-45% -$640 ﹤0.01% 4028
2015
Q1 		$1K Sell
362
-2,721
-88% -$9.67K ﹤0.01% 4085
2014
Q4 		$9K Buy
+3,083
New +$10.4K ﹤0.01% 2240
2014
Q3 		– Sell
-100
Closed – – 4710
2014
Q2 		$0 Buy
+100
New +$195 ﹤0.01% 4399
2014
Q1 		– Sell
-1,882
Closed -$4K – 4732
2013
Q4 		$4K Buy
1,882
+651
+53% +$1.53K ﹤0.01% 3683
2013
Q3 		$3K Buy
+1,231
New +$3.09K ﹤0.01% 3956

Other funds holding MNOV

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Tower Research Capital (TRC)'s MNOV Position: Q1 2026 in Review

Tower Research Capital (TRC) sold out of MediciNova (MNOV) in Q1 2026, closing a stake of 1,846 shares — an estimated $2.42K sold.

Tower Research Capital (TRC) first reported a position in MNOV in Q3 2013 and held it in 43 quarters. The position peaked at $228K in Q3 2020. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

  • Tower Research Capital (TRC) reported no remaining MediciNova position as of Q1 2026 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,846 MediciNova shares in Q1 2026, an estimated $2.42K.
  • Tower Research Capital (TRC) first reported a position in MediciNova in Q3 2013 and held it in 43 quarters.
  • Tower Research Capital (TRC)'s MediciNova position peaked at $228K in Q3 2020.
  • 30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.